Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?

References

• Adebisi A, Conway BR. (2011). Gastroretentive microparticles for drug delivery applications. J Microencapsul 28:689–708
   PubMed Web of Science ®Google Scholar
• Akala EO. (2010). Oral controlled release solid dosage forms. In: Jasti BR, Ghosh TK, eds. Theory and practice of contemporary pharmaceutics. 2nd ed. Florida: CRC Press, 333–66
   Google Scholar
• Akiyama Y, Nagahara N. (1999). Novel formulation approaches to oral mucoadhesive drug delivery systems. In: Mathiowitz E, Chickering DE III, Lehr CM, eds. Bioadhesive drug delivery systems – fundamentals, novel approaches and development. New York: Dekker, 477–505
   Google Scholar
• Ali J, Arora S, Ahuja A, et al. (2007). Formulation and development of hydrodynamically balanced system for metformin: in vitro and in vivo evaluation. Eur J Pharm Biopharm 67:196–201
   PubMed Web of Science ®Google Scholar
• Arora S, Ali J, Ahuja A, et al. (2005). Floating drug delivery system: a review. AAPS PharmSciTech 6:E372–E399. Article-47
   PubMed Web of Science ®Google Scholar
• Atyabi F, Sharma HL, Mohammad AH, Fell JT. (1996). In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J Control Release 42:105–13
   Web of Science ®Google Scholar
• Awasthi R, Kumar P, Pawar VK. (2010). Chronotherapy: science and technology of drug scheduling on the basis of biological rhythm. J Chronother Drug Deliv 1:1–8
   Google Scholar
• Awasthi R, Kulkarni GT. (2012). Development of novel gastroretentive floating particulate drug delivery system of gliclazide. Curr Drug Deliv 9:437–51
   PubMed Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT. (2014). Development of novel gastroretentive drug delivery system of gliclazide: hollow beads. Drug Dev Ind Pharm 40:398–408
   PubMed Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT, Pawar VK, Garg G. (2012). Optimization studies on gastroretentive floating system using response surface methodology. AAPS PharmSciTech 13:85–93
   PubMed Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT. (2013). Development and characterization of amoxicillin loaded floating microballoons for the treatment of Helicobacter pylori induced gastric ulcer. Asian J Pharm Sci 8:174–80
   Google Scholar
• Awasthi R, Pawar V, Kulkarni GT. (2010). Floating microparticulate systems: an approach to increase gastric retention. Indian J Pharm 1:17–26
   Google Scholar
• Babu VBM, Khar RK. (1990). In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate. Pharmazie 45:268–70
   PubMed Web of Science ®Google Scholar
• Badve SS, Sher P, Korde A, Pawar AP. (2007). Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm Biopharm 65:85–93
   PubMed Web of Science ®Google Scholar
• Bardonnet PL, Faivre V, Pugh WJ, et al. (2006). Gastroretentive dosage forms: overview and special case of Helicibacter pylori. J Control Release 111:1–18
   PubMed Web of Science ®Google Scholar
• Barmpalexis P, Kachrimanis K, Georgarakis E. (2011). Solid ispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. Eur J Pharm Biopharm 77:122–31
   PubMed Web of Science ®Google Scholar
• Baumgartner S, Krist J, Vreer F, et al. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 195:125–35
   PubMed Web of Science ®Google Scholar
• Bechgaard H, Ladefoged K. (1978). Distribution of pellets in the gastrointestinal tract: the influence on transit time exerted by density or diameter of pellets. J Pharm Pharmacol 30:690–2
   PubMed Web of Science ®Google Scholar
• Bera R, Mandal B, Bhowmik M, et al. (2009). Formulation and in vitro evaluation of sunflower oil entrapped within buoyant beads of furosemide. Sci Pharm 77:669–78
   Google Scholar
• Caldwell LJ, Gardner CR, Cargill RC. (1988a). Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent US 4,735,804
   Google Scholar
• Caldwell LJ, Gardner CR, Cargill RC, Higuchi T. (1988b). Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent US 4,758,436
   Google Scholar
• Caldwell LJ, Gardner CR, Cargill RC. (1988c). Drug delivery device which can be retained in the stomach for a controlled period of time. US Patent US 4,767,627
   Google Scholar
• Cargill R, Caldwell LJ, Engle K, et al. (1988). Controlled gastric emptying. 1. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs. Pharm Res 5:533–6
   PubMed Web of Science ®Google Scholar
• Castellanos NRJ, Zia H, Rhodes CT. (1993). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 19:143–94
   Web of Science ®Google Scholar
• Ceballos-Baumann AO, Kummer R, Eckert W, Weicker H. (1990). Controlled-release levodopa/benserazide (Madopar HBS): clinical observations and levodopa and dopamine plasma concentrations in fluctuating Parkinsonian patients. J Neurol 237:24–8
   PubMed Web of Science ®Google Scholar
• Chauhan B, Shimpi S, Mahadik KR, Paradkar A. (2004). Preparation and evaluation of floating risedronate sodium Gelucire® 39/01 matrices. Acta Pharm 54:205–14
   PubMedGoogle Scholar
• Chavanpatil MD, Jain P, Chaudhari S, et al. (2005). Development of sustained release gastroretentive drug delivery system for ofloxain: in vitro and in vivo evaluation. Int J Pharm 304:178–84
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Jain P, Chaudhari S, et al. (2006). Novel sustained release swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 316:86–92
   PubMed Web of Science ®Google Scholar
• Chawla G, Gupta P, Koradia V, Bansal AK. (2003). Gastroretention a means to address regional variability in intestinal drug absorption. Pharm Technol 6:50–68
   Google Scholar
• Chen J, Blevins WE, Park H, Park K. (2000). Gastric retention properties of superporous hydrogel composites. J Control Release 64:39–51
   PubMed Web of Science ®Google Scholar
• Chickering DE, Jacob JS, Mathowitz E. (1995). Bioadhesive microspheres II: characterisation and evaluation of bioadhesion involving hard, bioerodible polymers and soft tissue. React Polym 25:189–206
   Google Scholar
• Chien YW. (2009). Novel drug delivery systems. USA: Informa, Healthcare Inc
   Google Scholar
• Choudhury PK, Kar M, Chauhan CS. (2008). Cellulose acetate microspheres as floating depot system to increase gastric retention of antidiabetic drug: formulation, characteristics and in vitro-in vivo evaluation. Drug Dev Ind Pharm 34:349–54
   PubMed Web of Science ®Google Scholar
• Chouza C, Romero S, de Medina O, et al. (1987). Substitution of standard madopar by madopar HBS in parkinsonians with fluctuations. Eur Neurol 27:59–67
   PubMedGoogle Scholar
• Chun MK, Sah H, Choi HK. (2005). Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori. Int J Pharm 297:172–9
   PubMed Web of Science ®Google Scholar
• Clarke GM, Newton JM, Short MD. (1993). Gastrointestinal transit of pellets of differing size and density. Int J Pharm 100:81–92
   Web of Science ®Google Scholar
• Clarke GM, Newton JM, Short MB. (1995). Comparative gastrointestinal transit of pellet systems of varying density. Int J Pharm 114:1–11
   Web of Science ®Google Scholar
• Coupe AJ, Davis SS, Evans DF, Wilding IR. (1991). Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility. Pharm Res 8:1281–5
   PubMed Web of Science ®Google Scholar
• Coupe AJ, Davis SS, Evans DF, Wilding IR. (1993). Do pellet formulations empty from the stomach with food? Int J Pharm 92:167–75
   Web of Science ®Google Scholar
• Daniels IR, Allum WH. (2005). The anatomy and physiology of the stomach. In: Fielding JWL, Hallissey MT, eds. Upper gastrointestinal surgery. The Netherlands: Springer, 17–37
   Google Scholar
• Dave BS, Amin AF, Patel MM. (2004). Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech 5:77–82. Article 34
   Web of Science ®Google Scholar
• Davis SS. (2005). Formulation strategies for absorption windows. Drug Discov Today 10:249–57
   PubMed Web of Science ®Google Scholar
• Davis SS, Stockwell AF, Taylor MJ. (1986). The effect of density on the gastric emptying of single and multiple unit dosage forms. Pharm Res 3:208–13
   PubMed Web of Science ®Google Scholar
• Degtiareva II, Bogdanov A, Khatib Z, et al. (1994). The use of 3rd-generation antacid preparations for the treatment of patients with nonulcerous dyspepsia and peptic ulcer complicated by reflux esophagitis. Lik Sprava 5:119–22
   Google Scholar
• Deshpande AA, Rhodes CT, Shah NH, Malick AW. (1996). Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm 22:531–9
   Web of Science ®Google Scholar
• Dorozynski P, Kulinowski P, Jachowicz R, Jasinski A. (2007). Development of a system for simultaneous dissolution studies and magnetic resonance imaging of water transport in hydrodynamically balanced systems: a technical note. AAPS PharmSciTech 8:E1–4
   Google Scholar
• Dressman JB. (1986). Comparison of canine and human gastrointestinal physiology. Pharm Res 3:123–31
   PubMed Web of Science ®Google Scholar
• Durig T, Fassihi R. (2000). Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test. J Control Release 67:37–44
   PubMed Web of Science ®Google Scholar
• Eberle VA, Schoelkopf J, Gane PAC, et al. (2014). Floating gastroretentive drug delivery systems: comparison of experimental and simulated dissolution profiles and floatation behavior. Eur J Pharm Sci 58:34–43
   PubMed Web of Science ®Google Scholar
• El-Gibaly I. (2002). Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non8floating chitosan microspheres. Int J Pharm 249:7–21
   PubMed Web of Science ®Google Scholar
• Erni W, Held K. (1987). The hydrodynamically balanced system: a novel principle of controlled drug release. Eur Neurol 27:21–7
   PubMedGoogle Scholar
• Fabregas JL, Claramunt J, Cucala J, et al. (1994). In-vitro testing of an antacid formulation with prolonged gastric residence time (Almagate Flot-Coat). Drug Dev Ind Pharm 20:1199–212
   Web of Science ®Google Scholar
• Fell JT. (1996). Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. J Anat 189:517–9
   PubMed Web of Science ®Google Scholar
• Fix JA, Cargill R, Engle K. (1993). Controlled gastric emptying. III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm Res 10:1087–9
   PubMed Web of Science ®Google Scholar
• Fujimori J, Machida Y, Nagai T. (1994). Preparation of a magnetically-responsive tablet and configuration of its gastric residence in beagle dogs. STP Pharma Sci 4:425–30
   Google Scholar
• Gangadharappa HV, Kumar P, Kumar S. (2007). Gastric floating drug delivery systems: a review. Ind J Pharm Educ Res 41:295–305
   Web of Science ®Google Scholar
• Garg S, Gupta GD. (2008). Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 7:1055–66
   Web of Science ®Google Scholar
• Goole J, Gansbeke BV, Pilcer G, et al. (2008). Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. Int J Pharm 364:54–63
   PubMed Web of Science ®Google Scholar
• Goole J, Vanderbist F, Aruighi K. (2007). Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm 334:35–41
   PubMed Web of Science ®Google Scholar
• Gohel MC, Sarvaiya KG. (2007). A novel solid dosage form of rifampicin and isoniazid with improved functionality. AAPS PharmSciTech 8:E133–E139. Article 68
   Google Scholar
• Groning R, Berntgen M. (1996). Estimation of the gastric residence time of magnetic dosage forms using the heidelberg capsule. Pharmazie 51:328–31
   PubMed Web of Science ®Google Scholar
• Groning R, Berntgen M, Georgarakis M. (1998). Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm 46:285–91
   PubMed Web of Science ®Google Scholar
• Gupta PK, Robinson JR. (1995). Effect of volume and viscosity of coadministered fluid on gastrointestinal distribution of small particles. Int J Pharm 125:185–93
   Web of Science ®Google Scholar
• Gusler G, Berner B. (2000). Metformin (GRTM) gastric retentive tablets: GI transit and pharmacokinetics in healthy volunteers. Millenial World Congress of Pharm Sci.: San Francisco, 2–5019
   Google Scholar
• Gusler G, Gorsline J, Levy G, et al. (2001). Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. J Clin Pharmacol 41:655–61
   PubMed Web of Science ®Google Scholar
• Harding SE, Davis SS, Deacon MP, Fiebring I. (1999). Biopolymer mucoadhesives. Biotechnol Genet Eng Rev 16:41–86
   PubMed Web of Science ®Google Scholar
• Harrigan RM. (1977). Drug delivery device for preventing contact of undissolved drug with the stomach lining. US Patent US 4,055,178
   Google Scholar
• Hascicek C, Tilkan GY, Turkmen B, Ozdemir N. (2011). Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid. Acta Pharm 61:303–12
   PubMed Web of Science ®Google Scholar
• Hasler LH. (1995). Motility of the small intestine. In: Yamada T, ed. Textbook of gastroenterology II. Vol. 1. Philadelphia: J.B. Lippincott, 181–225
   Google Scholar
• He P, Davis SS, Illum L. (1999). Chitosan microspheres prepared by spay drying. Int J Pharm 187:53–65
   PubMed Web of Science ®Google Scholar
• Hejazi R, Amiji M. (2002). Stomach-specific anti H. pylori therapy I: preparation and characterization of tetracycline of a floating multiple-unit, capsule, a high-density loaded chitosan microcapsules. Int J Pharm 235:87–94
   PubMed Web of Science ®Google Scholar
• Hendee WR. (1994). Fundamentals of diagnostic imaging: characteristics of the radio-graphic image. In: Putman CE, Ravin CE, eds. Textbook of diagnostic imaging, Vol. 1. Philadelphia: WB Saunders Co., 9–10
   Google Scholar
• Hilton AK, Deasy PB. (1992). In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxicillin trihydrate. Int J Pharm 86:79–88
   Web of Science ®Google Scholar
• Hocking MP, Brunson ME, Vogel SB. (1988). Effect of various prokinetic agents on post Roux-en-Y gastric emptying. Digest Dis Sci 33:1282–7
   PubMed Web of Science ®Google Scholar
• Hoffmann AF, Pressman JH, Code CF, et al. (1983). Controlled entry of orally administered drugs: physiological considerations. Drug Dev Ind Pharm 9:1077–109
   Web of Science ®Google Scholar
• Hou SY, Cowles VE, Berner B. (2003). Gastric retentive dosage forms: a review. Crit Rev Ther Drug Carrier Syst 20:459–97
   PubMed Web of Science ®Google Scholar
• Hu L, Li L, Yang X, et al. (2011). Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers. Eur J Pharm Sci 42:99–105
   PubMed Web of Science ®Google Scholar
• Huang Y, Leobandung W, Foss A, Peppas NA. (2000). Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Release 65:63–71
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Park H, Park K. (1998). Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst 15:243–84
   PubMed Web of Science ®Google Scholar
• Iannuccelli V, Coppi G, Leo E, et al. (2000). PVP solid dispersion for the controlled release of furosemide from a floating multiple unit system. Drug Dev Ind Pharm 26:595–603
   PubMed Web of Science ®Google Scholar
• Iannuccelli V, Coppi G, Sansone R, Ferolla G. (1998). Air compartment multiple-unit for prolonged gastric residence part II. In vivo evaluation. Int J Pharm 174:55–62
   Web of Science ®Google Scholar
• Ingani HM, Timmermans J, Moes A. (1987). Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. Int J Pharm 35:157–64
   Web of Science ®Google Scholar
• Ishak RAH, Awad GAS, Mortada ND, Nour SAK. (2007). Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy. J Control Release 119:207–14
   PubMed Web of Science ®Google Scholar
• Jackson SJ, Bush D, Perkins AC. (2001). Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfate. Int J Pharm 212:55–62
   PubMed Web of Science ®Google Scholar
• Jain SK, Agrawal GP, Jain NK. (2006a). A novel calcium silicate based microspheres of repaglinide: in vivo investigations. J Control Release 113:111–6
   PubMed Web of Science ®Google Scholar
• Jain SK, Agrawal GP, Jain NK. (2006b). Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. AAPS PharmSciTech 7:E54–E62. Article 90
   PubMed Web of Science ®Google Scholar
• Jain SK, Awasthi AM, Jain NK, Agrawal GP. (2005). Calcium silicate based microspheres of repaglinide for gastroreteneive floating drug delivery: preparation and in-vitro characterization. J Control Release 107:300–9
   PubMed Web of Science ®Google Scholar
• Jain SK, Gupta A. (2009). Development of gelucire 43/01 beads of metformin hydrochloride for floating delivery. AAPS PharmSciTech 10:1128–36
   PubMed Web of Science ®Google Scholar
• Joseph NJ, Lakshmi S, Jayakrishnan A. (2002). A floating type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in-vitro and in-vivo evaluation in rabbits. J Control Release 79:71–9
   PubMed Web of Science ®Google Scholar
• Kale RD, Tyade PT. (2007). A multiple unit floating drug delivery system of piroxicam using eudragit polymer. Ind J Pharm Sci 1:120–4
   Google Scholar
• Kamath K, Park K. (1993). Biodegradable hydrogels in drug delivery. Adv Drug Deliv Rev 11:59–84
   Web of Science ®Google Scholar
• Kaus LC, Fell JT, Sharma H, Taylor DC. (1984). Gastric emptying and intestinal transit of non-disintegrating capsules the influence of metoclopramide. Int J Pharm 22:99–103
   Web of Science ®Google Scholar
• Kedzierewicz F, Thouvenot P, Lemut J, et al. (1999). Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J Control Release 58:195–205
   PubMed Web of Science ®Google Scholar
• Khosla R, Davis SS. (1987). The effect of polycarbophil on the gastric emptying of pellets. J Pharm Phamacol 39:47–9
   PubMed Web of Science ®Google Scholar
• Klausner EA, Lavy E, Friedman M, Hoffman A. (2003a). Expandable gastroretentive dosage forms. J Control Release 90:143–62
   PubMed Web of Science ®Google Scholar
• Klausner EA, Lavy E, Barta M, et al. (2003b). Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans. Pharm Res 20:1466–73
   PubMed Web of Science ®Google Scholar
• Laby RH. (1974). Device for administration to ruminants. US Patent US 3,844,285
   Google Scholar
• Lee JW, Park JH, Robinson JR. (2000). Bioadhesive-based dosage forms: the next generation. J Pharm Sci 89:850–66
   PubMed Web of Science ®Google Scholar
• Lee VHL, Mukherjee SK. (2006). Drug delivery: oral colon8specific. In: Swarbrick J, ed. Encyclopedia of pharmaceutical technology. London: Informa Healthcare, 1228–41
   Google Scholar
• Lee JH, Park TG, Lee YB, et al. (2001). Effect of adding non-volatile oil as a core material for the floating microspheres prepared by emulsion solvent diffusion method. J Microencapsul 18:65–75
   PubMed Web of Science ®Google Scholar
• Lehr CM. (1994). Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst 11:119–60
   PubMed Web of Science ®Google Scholar
• Lippold BC, Gunther J. (1991). In-vivo Prufung einer multipartikularen Retard-Schwimmarzneiform. Eur J Pharm Biopharm 37:254–61
   Web of Science ®Google Scholar
• Longer MA, Ching HS, Robinson JR. (1985). Bioadhesive polymers as platform for oral control drug delivery III-oral delivery of chlorthiazide using bioadhesive polymer. J Pharm Sci 74:406–10
   PubMed Web of Science ®Google Scholar
• Marieb EN. (2007). Essentials of human anatomy and physiology. 1st ed: Delhi: Pearsons Education
   Google Scholar
• Martinez IJ, Ramirez AMD, Robles LV. (2010). Effect of antioxidants on captopril floating matrices. Pharm Dev Technol 15:230–40
   PubMed Web of Science ®Google Scholar
• Mayur C, Senthilkumaran K, Hemant G. (2013). Super porous hydrogels: a recent advancement in gastroretentive drug delivery system. Indonesian J Pharm 24:1–13
   Google Scholar
• Mazer N, Abisch E, Gfeller JC, et al. (1988). Intragastric behavior and absorption kinetics of a normal and “floating” modified-release capsule of isradipine under fasted and fed conditions. J Pharm Sci 77:647–57
   PubMed Web of Science ®Google Scholar
• Mendyk A, Jachowicz R, Dorozynski P. (2006). Artificial neural networks in the modeling of drugs release profiles from hydrodynamically balanced systems. Acta Poloniae Pharm Drug Res 63:75–80
   PubMedGoogle Scholar
• Michaels AS. (1974). Drug delivery device with self-actuated mechanism for retaining device in selected area. US Patent US 3,786,813
   Google Scholar
• Michaels AS, Bashwa JD, Zaffaroni A. (1975). Integrated device for administering beneficial drug at programmed rate. US Patent US 3,901,232
   Google Scholar
• Mojaverian P, Vlasses PH, Kellner PE, Rocci ML. (1988). Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations. Pharm Res 10:639–44
   Web of Science ®Google Scholar
• Mostafavi A, Emami J, Varshosaz J, et al. (2011). Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers. Int J Pharm 409:128–36
   PubMed Web of Science ®Google Scholar
• Mouzam MI, Dehghan MHG, Asif S, et al. (2011). Preparation of a novel floating ring capsule-type dosage form for stomach specific delivery. Saudi Pharm J 19:85–93
   PubMed Web of Science ®Google Scholar
• Muthusamy K, Govindarazan G, Ravi TK. (2005). Preparation and evaluation of Lansoprazole floating micropellets. Indian J Pharm Sci 67:75–9
   Google Scholar
• Nakagawa T, Kondo SI, Sasai Y, Kuzuya M. (2006). Preparation of floating drug delivery system by plasma technique. Chem Pharm Bull 54:514–8
   PubMed Web of Science ®Google Scholar
• Nakamichi K, Yasuura H, Fukui H, et al. (2001). Evaluation of a floating dosage form of nicardipine hydrochloride and hydroxypropylmethylcellulose acetate succinate prepared using a twin-screw extruder. Int J Pharm 218:103–12
   PubMed Web of Science ®Google Scholar
• Nama M, Gonugunta CSR, Veerareddy PR. (2008). Formulation and evaluation of gastroretentive dosage forms of clarithromycin. AAPS PharmSciTech 9:231–7
   PubMed Web of Science ®Google Scholar
• Narayana CR, Basavaraj BV, Madhavan V. (2010). Microballoons of famotidine: a non-effervescent gastroretentive controlled drug delivery system using Eudragit L-100. Der Pharm Lett 2:176–89
   Google Scholar
• Nepal PR, Chun MK, Choi HK. (2007). Preparation of floating microspheres for fish farming. Int J Pharm 341:85–90
   PubMed Web of Science ®Google Scholar
• Oh TO, Kim JY, Ha JM, et al. (2013). Preparation of highly porous gastroretentive metformin tablets using a sublimation method. Eur J Pharm Biopharm 83:460–7
   PubMed Web of Science ®Google Scholar
• Omidian H, Rocca JG, Park K. (2005). Advances in superporous hydrogels. J Control Release 102:3–1012
   PubMed Web of Science ®Google Scholar
• O'Reilly S, Wilson CG, Hardy JG. (1987). The influence of food on the gastric emptying of multiparticulate dosage forms. Int J Pharm 34:213–6
   Web of Science ®Google Scholar
• Park H, Park K, Shalaby WSW. (1993). Biodegradable hydrogels for drug delivery. PA, USA: Technomic Publishing Co., Inc
   Google Scholar
• Patel DM, Patel NM, Pandya NN, Jogani PD. (2007a). Gastroretentive drug delivery system of carbamazepine: formulation optimization using simplex lattice design: a technical note. AAPS Pharma Sci Tech 8:E82–E86. Article 11
   PubMedGoogle Scholar
• Patel DM, Patel NM, Patel VF, Bhatt DA. (2007b). Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS PharmSciTech 8:E25–E31. Article 30
   PubMed Web of Science ®Google Scholar
• Pawar VK, Kansal S, Garg G, et al. (2011). Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv 18:97–110
   PubMed Web of Science ®Google Scholar
• Phuapradit W, Bolton S. (1991). The influence of tablet density on the human oral absorption of sustained release acetaminophen tablets. Drug Dev Ind Pharm 17:1097–107
   Web of Science ®Google Scholar
• Pies R. (1982). Value of once daily dosing of diazepam questioned-and defended. J Clin Psychopharmacol 2:355–6
   PubMed Web of Science ®Google Scholar
• Ponchel G, Irache JM. (1998). Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 34:191–219
   PubMed Web of Science ®Google Scholar
• Qiu Y, Park K. (2003). Superporous IPN hydrogels having enhanced mechanical properties. AAPS PharmSciTech 4:406–412. Article 51
   Google Scholar
• Rahman Z, Ali M, Khar RK. (2006). Design and evaluation of bilayer floating tablets of captopril. Acta Pharm 56:49–57
   PubMedGoogle Scholar
• Rajinikanth PS, Balasubramanium J, Mishra B. (2007). Development and evaluation a novel floating in situ gelling system of amoxicillin for eradicating of Helicobacter pylori. Int J Pharm 335:114–22
   PubMed Web of Science ®Google Scholar
• Rajinikanth PS, Mishra B. (2008). Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori. J Control Release 125:33–41
   PubMed Web of Science ®Google Scholar
• Ravala JA, Patel JK, Li N, et al. (2007). Ranitidin hydrochloride floating matrix tablets based on low density powder: effects of formulation and prossing parameters on drug release. Asian J Pharm Sci 2:130–42
   Google Scholar
• Reddy LH, Murthy RS. (2002). Floating dosage forms in drug delivery. Crit Rev Ther Drug Carrier Syst 19:553–85
   PubMed Web of Science ®Google Scholar
• Romanski KW. (2009). Migrating motor complex in biological sciences: characterization, animal models and disturbances. Indian J Exp Biol 47:229–44
   PubMed Web of Science ®Google Scholar
• Rouge N, Leroux JC, Cole ET, et al. (1997). Prevention of sticking tendency of floating mini tablets filled into hard gelatin capsules. Eur J Pharm Biopharm 43:165–71
   Web of Science ®Google Scholar
• Rouge N, Allemann E, Gex-Fabry M, et al. (1998). Comparative pharmacokinetic study of a floating multiple-unit capsule, a high density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helbetiae 73:81–7
   PubMedGoogle Scholar
• Rubinstein A, Friend DR. (1994). Specific delivery to the gastrointestinal tract. In: Domb AJ, ed. Polymeric site-specific pharmacotherapy. Chichester: Wiley, 282–3
   Google Scholar
• Sakkinen M, Tuononen T, Jurjenson H, et al. (2003). Evaluation of microcrystalline chitosans for gastro-retentive drug delivery. Eur J Pharm Sci 19:345–53
   PubMed Web of Science ®Google Scholar
• Sakkinen M, Marvola J, Kanerva H, et al. (2004). Gamma scintigraphic evaluation of the fate of microcrystalline chitosan granules in human stomach. Eur J Pharm Biopharm 57:133–43
   PubMed Web of Science ®Google Scholar
• Sangekar S, Vadino WA, Chaudry I, et al. (1987). Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int J Pharm 35:187–91
   Web of Science ®Google Scholar
• Sarna SK. (1985). Cyclic motor activity; migrating motor complex. Gastroenterology. 89:894–913
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. (2004). In- vitro and in-vivo evaluation of riboflavin-containing microballoons for a controlled drug delivery system in healthy humans. Int J Pharm 275:97–107
   PubMed Web of Science ®Google Scholar
• Sawicki W. (2002). Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. Eur J Pharm Biopharm 53:29–35
   PubMed Web of Science ®Google Scholar
• Schemann M, Ehrlein HJ. (1986). Mechanical characteristics of phase II and phase III of the interdigestive migrating motor complex in dogs. Gastroenterology 91:117–23
   PubMed Web of Science ®Google Scholar
• Seth PR, Tossounian J. (1984). The hydrodynamically balanced system, a novel drug delivery system for oral use. Drug Dev Ind Pharm 10:313–39
   Web of Science ®Google Scholar
• Shaha SH, Patel JK, Pundarikakshu Dua K, Patel NV. (2009). An overview of a gastro-retentive floating drug delivery system. Asian J Pharm Sci 4:65–80
   Google Scholar
• Shahiwala A. (2011). Formulation approaches in enhancement of patient compliance to poral drug therapy. Expert Opin Drug Deliv 8:1521–9
   PubMed Web of Science ®Google Scholar
• Sharma S, Pawar A. (2006). Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 313:150–8
   PubMed Web of Science ®Google Scholar
• Shen SI, Jasti BR, Li X. (2003). Design of controlled-release drug delivery systems. In: Myer K, ed. Standard handbook of biomedical engineering and design. New York: McGraw-Hill, 5.1–5.14
   Google Scholar
• Shimpi S, Chauhan B, Mahadik RK, Paradkar A. (2004). Preparation and evaluation of diltiazem hydrochloride-glucire 43/01 floating granules prepared by melt granulation. AAPS PharmSciTech 5:51–66. Article 43
   Google Scholar
• Shishu Gupta N, Aggarwal N. (2007a). Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads. AAPS PharmSciTech 8:E143–E149. Article 48
   Google Scholar
• Shishu Gupta N, Aggarwal N. (2007b). A gastro-retentive floating delivery system for 5-fluorouracil. Asian J Pharm Sci 2:143–9
   Google Scholar
• Siegel RA, Rathbone MJ. (2012). Overview of controlled release mechanisms. In: Siepmann J, ed. Fundamentals and applications of controlled release drug delivery, advances in delivery science and technology. Controlled Release Society. Netherlands: Springer, 19–43
   Google Scholar
• Singh BN, Kim KH. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 63:235–59
   PubMed Web of Science ®Google Scholar
• Sonara GS, Jaina DK, Moreb DM. (2007). Preparation and in vitro evaluation of bilayer and floating-bioadhesive tablets of rosiglitazone maleate. Asian J Pharm Sci 2:161–9
   Google Scholar
• Soppimath KS, Aminabhavi TM, Agnihotri SA, et al. (2006). Effect of coexipients on nifedipine hollow microspheres: a novel gastroretentive drug delivery system. J Appl Polym Sci 100:486–94
   Web of Science ®Google Scholar
• Soppimath KS, Kulkarni AR, Aminabhavi TM. (2001). Development of hollow microspheres as floating controlled-release system for cardiovascular drugs: preparation and release characteristics. Drug Dev Ind Pharm 27:507–15
   PubMed Web of Science ®Google Scholar
• Srivastava AK, Ridhurkar DN, Wadhwa S. (2005). Floating microsphere of cimetidine: formulation, characterization and in-vivo evaluation. Acta Pharm 55:277–85
   PubMedGoogle Scholar
• Sriamornsak P, Thirawong N, Puttipipatkhachorn S. (2004). Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. AAPS J 6:65–71. Article 24
   Web of Science ®Google Scholar
• Stithit S, Chen W, Price JC. (1998). Development and characterization of buoyant theophylline microspheres with near zero order release kinetics. J Microencapsul 15:725–37
   PubMed Web of Science ®Google Scholar
• Stockwell AF, Davis SS, Walker SE. (1986). In vitro evaluation of alginate gel system as sustained release drug delivery system. J Control Release 3:167–75
   Google Scholar
• Streubel A, Siepmann J, Bodmeier R. (2006). Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 6:501–8
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. (2002). Floating microparticles based on low density foam powder. Int J Pharm 241:279–92
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. (2003a). Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci 18:37–45
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. (2003b). Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J Microencapsul 20:329–47
   PubMed Web of Science ®Google Scholar
• Strubing S, Abboud T, Contri RV, et al. (2008b). New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Eur J Pharm Biopharm 69:708–717
   PubMed Web of Science ®Google Scholar
• Strubing S, Metz H, Mader K. (2008a). Characterization of poly (vinyl acetate) based floating matrix tablets. J Control Release 126:149–55
   PubMed Web of Science ®Google Scholar
• Sugihara H, Matsui Y, Takeuchi H, et al. (2014). Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies. Eur J Pharm Sci 53:62–8
   PubMed Web of Science ®Google Scholar
• Sungthongjeen S, Sriamornsak P, Puttipipatkhachorn S. (2008). Design and evaluation of floating multi-layer coated tablets based on gas formation. Eur J Pharm Biopharm 69:255–63
   PubMed Web of Science ®Google Scholar
• Takahashi T. (2012). Mechanism of interdigestive migrating motor complex. J Neurogastroenterol Motil 18:246–57
   PubMed Web of Science ®Google Scholar
• Talukder R, Fassihi R. (2004). Gastroretentive delivery systems: hollow beads. Drug Dev Ind Pharm 30:405–12
   PubMed Web of Science ®Google Scholar
• Tanwar YS, Naruka PS, Ojha GR. (2008). Development and evaluation of floating microspheres of verapamil hydrochloride. Brazil J Pharm Sci 43:1–6
   Google Scholar
• Timmermans J, Moes AJ. (1994). Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. J Pharm Sci 83:18–24
   PubMed Web of Science ®Google Scholar
• Tortora GJ, Derrickson BH. (2011). Principles of anatomy and physiology, 11th ed. Hoboken, NJ: John Wiley and Sons
   Google Scholar
• Tuleu C, Andrieux C, Boy P, Chaumeil JC. (1999). Gastrointestinal transit of pellets in rats: effect of size and density. Int J Pharm 180:123–31
   PubMed Web of Science ®Google Scholar
• Umamaheshwari RB, Jain S, Bhadra D, Jain NK. (2006). Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol 55:1607–13
   Web of Science ®Google Scholar
• Umamaheshwari RB, Jain S, Tripathi PK, et al. (2002). Floating bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug Deliv 9:223–31
   PubMed Web of Science ®Google Scholar
• Umamaheshwari RB, Jain S, Jain NK. (2003). A new approach in gasreoretentive drug delivery system using cholestyramine. Drug Deliv 10:151–60
   PubMed Web of Science ®Google Scholar
• Vantrappen GR, Peeters TL, Janssens J. (1979). The secretory component of interdigestive migratory motor complex in man. Scand J Gastroenterol 14:663–7
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tavakoli N, Roozbahani F. (2006). Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended release tablets. Drug Deliv 13:277–85
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Zahrooni M. (2007). Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsul 24:253–62
   PubMed Web of Science ®Google Scholar
• Wakode RR, Bajaj AN. (2008). Formulation and characterization of pramipexole loaded microspheres
   Google Scholar
• Washington N, Washington C, Wilson CG, Davis SS. (1986). What is “Liquid Gaviscon”? A comparison of four international formulations. Int J Pharm 34:105–9
   Web of Science ®Google Scholar
• Washington N, Wilson CG, Greaves JL, Danneskiold-Samsoe P. (1988). An investigation into the floating behaviour of a pectin-containing anti-reflux formulation (FF5005) by means of gamma scintigraphy. Scand J Gastroenterol 23:920–4
   PubMed Web of Science ®Google Scholar
• Waterman KC. (2007). A critical review of gastric retentive controlled drug delivery. Pharm Dev Technol 12:1–10
   PubMed Web of Science ®Google Scholar
• Waugh A, Grant A. (2001). Anatomy and physiology in health and illness. 9th ed. Churchill Livingstone: Elsevier
   Google Scholar
• Whitehead L, Fell JT, Collett JH, et al. (1998). Floating dosage forms: an in-vivo study demonstrating prolonged gastric retention. J Control Release 55:3–12
   PubMed Web of Science ®Google Scholar
• Wilding IR, Coupe AJ, Davis SS. (2001). The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev 46:103–24
   PubMed Web of Science ®Google Scholar
• Wilson CG, Crowley PJ, eds. (2011). Controlled release in oral drug delivery series. Advances in delivery science and technology. Controlled Release Society. Netherlands: Springer
   Google Scholar
• Wilson CG, Washington N. (1989). The stomach: its role in oral drug delivery. In: Rubinstein MH, ed. Physiological pharmaceutical: biological barriers to drug absorption. UK: Ellis Horwood, 47–70
   Google Scholar
• Xiaoqiang X, Minjie S, Feng Z, Yiqiao H. (2006). Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int J Pharm 310:139–45
   PubMed Web of Science ®Google Scholar
• Xu WL, Tu XD, Lu ZD. (1991). Development of gentamicin sulfate sustained-release tablet floating in stomach. Yaoxue Xuebao 26:541–5
   Google Scholar
• Yang L, Eshraghi J, Fassihi R. (1999). A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: In vitro evaluation. J Control Release 57:215–22
   PubMed Web of Science ®Google Scholar
• Zheng J, Liu C, Bao D, et al. (2006). Preparation and evaluation of floating bioadhesive microparticles containing clarithromcin for the eradication of Helicobacter pylori. J Appl Polym Sci 102:2226–32
   Web of Science ®Google Scholar